Paul Workman Selected Research

Lactic Acid (Lactate)

7/2017	Pediatric and adult glioblastoma radiosensitization induced by PI3K/mTOR inhibition causes early metabolic alterations detected by nuclear magnetic resonance spectroscopy.
1/2017	In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells.
12/2016	The BRAF Inhibitor Vemurafenib Activates Mitochondrial Metabolism and Inhibits Hyperpolarized Pyruvate-Lactate Exchange in BRAF-Mutant Human Melanoma Cells.
1/2014	Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastoma.
7/2013	MEK1/2 inhibition decreases lactate in BRAF-driven human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Workman Research Topics

Disease

163	Neoplasms (Cancer) 10/2023 - 01/2002
16	Melanoma (Melanoma, Malignant) 01/2018 - 10/2006
14	Colonic Neoplasms (Colon Cancer) 01/2023 - 06/2002
14	Carcinoma (Carcinomatosis) 11/2013 - 01/2004
12	Glioblastoma (Glioblastoma Multiforme) 10/2017 - 03/2009
9	Ovarian Neoplasms (Ovarian Cancer) 11/2018 - 07/2002
7	Carcinogenesis 01/2023 - 01/2004
6	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 03/2011
6	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2003
6	Hypoxia (Hypoxemia) 06/2011 - 07/2002
5	Breast Neoplasms (Breast Cancer) 05/2017 - 01/2006
4	Neoplasm Metastasis (Metastasis) 04/2008 - 01/2002
3	Neuroblastoma 11/2020 - 11/2011
3	Cholangiocarcinoma 01/2020 - 01/2017
3	Glioma (Gliomas) 09/2009 - 01/2009
2	Adenocarcinoma 01/2023 - 11/2021
2	Chordoma 01/2021 - 01/2019
2	Leukemia 01/2020 - 11/2004
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 10/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 06/2014
2	Fatigue 01/2019 - 10/2008
2	Disease Progression 10/2017 - 06/2009
2	Ovarian Epithelial Carcinoma 01/2015 - 03/2008
2	Multiple Myeloma 10/2013 - 01/2012

Drug/Important Bio-Agent (IBA)

45	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2002
30	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2023 - 01/2002
27	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2005
26	Molecular Chaperones (Chaperone, Molecular)IBA 01/2023 - 01/2002
22	tanespimycin (17AAG)IBA 01/2023 - 01/2002
20	Phosphotransferases (Kinase)IBA 01/2019 - 10/2004
9	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020 - 01/2004
9	Phosphorylcholine (Phosphocholine)IBA 07/2017 - 11/2003
8	PI103IBA 01/2017 - 06/2007
8	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 08/2013 - 10/2006
7	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2012
7	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 01/2002
6	Adenosine Triphosphate (ATP)IBA 01/2020 - 04/2009
6	RoscovitineIBA 01/2018 - 01/2004
6	Protein Isoforms (Isoforms)IBA 05/2017 - 09/2008
6	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2014 - 01/2006
6	Adenosine Triphosphatases (ATPase)IBA 01/2012 - 06/2004
5	Temozolomide (Temodar)FDA LinkGeneric 11/2020 - 02/2009
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 04/2005
5	Lactic Acid (Lactate)FDA LinkGeneric 07/2017 - 07/2013
5	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2016 - 09/2008
5	Phosphorus (Red Phosphorus)IBA 01/2014 - 11/2003
4	LigandsIBA 12/2021 - 03/2007
4	RNA (Ribonucleic Acid)IBA 12/2021 - 10/2003
4	Choline (Choline Chloride)IBA 01/2017 - 01/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 12/2007
4	Protons (Proton)IBA 01/2014 - 11/2003
4	Aurora KinasesIBA 10/2012 - 05/2004
4	EnzymesIBA 09/2012 - 05/2004
4	LAQ824IBA 02/2012 - 08/2006
4	Histone Deacetylase InhibitorsIBA 02/2012 - 08/2006
4	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2012 - 01/2008
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2012 - 09/2008
4	Imatinib Mesylate (Gleevec)FDA Link 09/2009 - 12/2003
3	ErbB Receptors (EGF Receptor)IBA 12/2021 - 05/2009
3	MicroRNAs (MicroRNA)IBA 11/2021 - 01/2007
3	Drug CombinationsIBA 01/2019 - 05/2012
3	Amino Acids FDA Link 10/2017 - 04/2009
3	Messenger RNA (mRNA)IBA 07/2017 - 02/2006
3	MTOR InhibitorsIBA 07/2017 - 01/2016
3	ProteomeIBA 01/2016 - 12/2009
3	Protein Kinases (Protein Kinase)IBA 11/2015 - 09/2008
3	Histones (Histone)IBA 05/2013 - 05/2004
3	Choline KinaseIBA 05/2012 - 01/2006
3	LipidsIBA 01/2012 - 06/2007
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2012 - 07/2002
3	Complementary DNA (cDNA)IBA 03/2011 - 02/2004
3	Phospholipids (Phosphatides)FDA LinkGeneric 07/2010 - 11/2003
3	Cytotoxins (Cytolysins)IBA 06/2009 - 05/2005
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 03/2007 - 12/2005
3	geldanamycinIBA 03/2006 - 01/2002
2	Complement System Proteins (Complement)IBA 10/2023 - 01/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2021 - 10/2004
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 10/2004
2	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 10/2003
2	Brachyury protein (Brachyury)IBA 01/2021 - 01/2019
2	CYC065IBA 11/2020 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 07/2002
2	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 01/2016
2	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 01/2019 - 01/2016
2	Carboplatin (JM8)FDA LinkGeneric 11/2018 - 10/2008
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 09/2011
2	Phosphatidylcholines (Phosphatidylcholine)IBA 10/2017 - 01/2016
2	VemurafenibIBA 12/2016 - 01/2013
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 04/2016 - 09/2008
2	Mediator ComplexIBA 02/2016 - 12/2015
2	N-Myc Proto-Oncogene ProteinIBA 01/2016 - 11/2011
2	Hormones (Hormone)IBA 01/2016 - 11/2015
2	Ribosomal Proteins (Ribosomal Protein)IBA 01/2015 - 05/2010
2	Small Interfering RNA (siRNA)IBA 05/2014 - 02/2009
2	Therapeutic UsesIBA 05/2013 - 04/2008

Therapy/Procedure

47	Therapeutics 01/2022 - 01/2002
11	Drug Therapy (Chemotherapy) 11/2021 - 10/2004
4	Precision Medicine 01/2022 - 12/2006
4	Castration 12/2021 - 03/2011
3	Radiotherapy 07/2017 - 06/2011